ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,245.70
0.90%
S&P ASX All Technology
3,774.20
1.78%
Brent Oil
73.185
-0.03%
US Dollar vs AUD
1.60452
-0.19%
Bitcoin
93,440.87
-0.85%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Regeneron Pharmaceuticals Inc (0R2M) Share Price

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (0R2M)

LSE
296.60
0.00
( 0.00% )
Updated: 11:00:00
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
296.60
Bid
0.00
Offer
0.00
Volume
4
0.00 Day's Range 0.00
296.60 52 Week Range 296.60
Market Cap
32.054B
Previous Close
296.60
Open
-
Last Trade
219
@
695.01
(O)
Last Trade Time
12:00:05
Financial Volume
-
VWAP
-
Average Volume (3m)
1,254
Shares Outstanding
108,072,000
Dividend Yield
-
PE Ratio
17.11
Earnings Per Share (EPS)
40.83
Revenue
14.2B
Net Profit
4.41B

About Regeneron Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Health Care Diversified
Website
www.regeneron.com
Headquarters
New York, New York, USA
Founded
1988
Regeneron Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0R2M. The last closing price for Regeneron Pharmaceuticals was US$296.60. Over the last year, Regeneron Pharmaceuticals shares have traded in a share price range of US$ 296.60 to US$ 296.60.

Regeneron Pharmaceuticals currently has 108,072,000 shares in issue. The market capitalisation of Regeneron Pharmaceuticals is US$32.05 billion. Regeneron Pharmaceuticals has a price to earnings ratio (PE ratio) of 17.11.

Ask ADVFN Intelligence (AI)

0R2M Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100296.6296.6296.6225296.6DE
400296.6296.6296.61456296.6DE
1200296.6296.6296.61254296.6DE
2600296.6296.6296.61080296.6DE
5200296.6296.6296.61049296.6DE
15600296.6296.6296.61735296.6DE
26000296.6296.6296.61505296.6DE

0R2M - Frequently Asked Questions (FAQ)

What is the current Regeneron Pharmaceuticals share price?
The current share price of Regeneron Pharmaceuticals is US$ 296.60
How many Regeneron Pharmaceuticals shares are in issue?
Regeneron Pharmaceuticals has 108,072,000 shares in issue
What is the market cap of Regeneron Pharmaceuticals?
The market capitalisation of Regeneron Pharmaceuticals is USD 32.05B
What is the 1 year trading range for Regeneron Pharmaceuticals share price?
Regeneron Pharmaceuticals has traded in the range of US$ 296.60 to US$ 296.60 during the past year
What is the PE ratio of Regeneron Pharmaceuticals?
The price to earnings ratio of Regeneron Pharmaceuticals is 17.11
What is the cash to sales ratio of Regeneron Pharmaceuticals?
The cash to sales ratio of Regeneron Pharmaceuticals is 5.32
What is the reporting currency for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Regeneron Pharmaceuticals?
The latest annual turnover of Regeneron Pharmaceuticals is USD 14.2B
What is the latest annual profit for Regeneron Pharmaceuticals?
The latest annual profit of Regeneron Pharmaceuticals is USD 4.41B
What is the registered address of Regeneron Pharmaceuticals?
The registered address for Regeneron Pharmaceuticals is 28 LIBERTY STREET, NEW YORK, NEW YORK, 10005
What is the Regeneron Pharmaceuticals website address?
The website address for Regeneron Pharmaceuticals is www.regeneron.com
Which industry sector does Regeneron Pharmaceuticals operate in?
Regeneron Pharmaceuticals operates in the HEALTH CARE DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ADMEAdm Energy Plc
0.21p
(40.00%)
8.77M
PATPanthera Resources Plc
11.50p
(21.05%)
4.19M
GSCUGreat Southern Copper Plc
3.00p
(20.00%)
19.32M
BBBBigblu Broadband Plc
33.00p
(17.86%)
183.63k
HE1Helium One Global Ltd
1.065p
(17.03%)
227.06M
SFRSeverfield Plc
26.40p
(-44.65%)
8.03M
GWMOGreat Western Mining Corporation Plc
0.0085p
(-19.05%)
280.84M
ROQRoquefort Therapeutics Plc
1.50p
(-16.67%)
1.68M
EUAEurasia Mining Plc
5.10p
(-16.39%)
47.3M
NOGNostrum Oil & Gas Plc
3.01p
(-14.00%)
1.76k
SYMESupply@me Capital Plc
0.0035p
(9.38%)
463.62M
GWMOGreat Western Mining Corporation Plc
0.0085p
(-19.05%)
280.84M
MSMNMosman Oil And Gas Limited
0.03p
(-9.09%)
265.06M
HE1Helium One Global Ltd
1.065p
(17.03%)
227.06M
TRPTower Resources Plc
0.023p
(-6.12%)
181.11M

Discussion

View Full Feed
ilovetech ilovetech 4 minutes ago
So it's not only Trading212, but also Interactive brokers, both, still blocking buys, but not sales.
NWBO
Monksdream Monksdream 4 minutes ago
HOLO, in the top 15 bouncing from a 52 week low
HOLO
D-man4 D-man4 4 minutes ago
🚀🚀🚀
AZRH
jctrdr jctrdr 5 minutes ago
$3 or NO Deal!!!!
ELTP
KISSINGER KISSINGER 5 minutes ago
How can I short pennies? Because I am a partner in a self clearing firm that does not require me to put up capital since our initial capital call for all 5 partners was $5 MM and thats almost 15 years ago. The island of Jersey is a great place. Have your opinions you are entitled to them. I made my
ATVK EPAZD
BlazingStocks BlazingStocks 5 minutes ago
$ILLR News March 02, 2025

Triller Group Inc. (NASDAQ: ILLR): A Hidden Gem in the Creator Economy with Explosive Upside Potential
https://www.insiderfinancial.com/post/triller-group-inc-nasdaq-illr-a-hidden-gem-in-the-creator-economy-with-explosive-upside-potential
ILLR
ExtremelyBullishZig ExtremelyBullishZig 5 minutes ago
But then in reality when the market looks at a company without any revenue and a small potential for getting revenue, it is very overvalued...
AVXL
blackhawks blackhawks 5 minutes ago
Why do you presume the problem is being ignored, why so incurious to look it up?

current evidence suggests that much of the observed increase reflects progress in recognizing and addressing ASD.

https://www.perplexity.ai/

Sociodemographic and Cultural Sh
Destiny Defined Destiny Defined 5 minutes ago
Just some idiot doing what idiots do.
ELTP
jay_tee jay_tee 5 minutes ago
Filter the ONLY fraud here is Seamus UNTIL he proves otherwise. Plain and simple. He has absolutely NO character. Let's put all the ups and downs of the market aside and the struggles of running a company. Seamus is still azz...from a purely moral standpoint and just being a responsible ceo.. There'
RNVA
Mr. Dragon Mr. Dragon 6 minutes ago
But can Firefly still undersell the competition with the tariffs figured in?
NIO
Sell4Profit Sell4Profit 6 minutes ago
You nailed this one Mark! BTOG
BTOG
Zardiw Zardiw 6 minutes ago
Yup. Expecting $IFUS to reach $5 or so when that India deal gets announced this week...........

Z
IFUS
TheHappyVulcan TheHappyVulcan 6 minutes ago
What he said .

You haven't lost until/unless you have sold.

THV.
CLHI
Phaedrus77 Phaedrus77 6 minutes ago
RC offer now worth less than $5 + cvr. I wouldn’t trust Kenney et al to run an ice cream shop.
stark12 stark12 7 minutes ago
I'm an author and have a lot of writing experience in both fiction and nonfiction. I strongly suspect AI wrote segments of the piece, if not the whole thing.
NB
SPORT19 SPORT19 7 minutes ago
News coming!

Close at or above.015
PKTX
BCNstocks BCNstocks 8 minutes ago
Agreed! No dilution. Nice to see in an OTC stock, with plans to uplist. Article out covering this:

ADIA Nutrition (OTC: ADIA) Expands, Eyes OTCQB Uplisting
https://allcapresearch.com/f/adia-nutrition-otc-adia-expands-eyes-otcqb-uplisting
ADIA
Trooperstocks Trooperstocks 8 minutes ago
$ILLR (Nasdaq: ILLR) Conor McGregor has flirted with the idea of crossing over to Bare Knuckle Fighting Championship [BKFC].

‘Notorious’ is a co-owner of BKFC, and excited about the idea of taking off the gloves for a scrap. https://bloodyelbow.com/2025/03/01/conor-mcgregor-drops-majo
ILLR
TAB78 TAB78 8 minutes ago
$WNBD Niagara Mist Perfume. Our 2025 strategy includes possibly expanding our SKU kit beyond only a female scent, to include also a male and unisex fragrance to round out the offering. Our new strategic partner, based in Dubai, has extensive experience in the "internationalization" of our Official
WNBD
$Gambler $Gambler 8 minutes ago
Link to Friday's upcoming Market Shakers - https://thecryptobasic.com/2025/03/03/why-march-7-is-crucial-for-bitcoin-and-the-broader-crypto-market/
CGAC
Fiberrevo9 Fiberrevo9 9 minutes ago
News about production must be just around the corner, the 24/7 marketnewsalert from friday describes the possibilities and unlimited potential for spidersilk very well......

But as always, this stock is only at this ridiculous pps because it is heavily manipulated by people who have t
KBLB
ElectricJester54 ElectricJester54 10 minutes ago
Indeed, hopefully it begins today. Plus this is the month of Button Energy, which is set to close by March 31st so we could be getting that news any day this month as well. Hopefully March this year is the beginning of the new paradigm for AZRH where the market finally realizes the value here.
AZRH
kip128932156 kip128932156 10 minutes ago

https://x.com/nicosintichakis/status/1896555429548970459?s=46&t=L_hszGlrG7Qfo9Ksml
FNMA

Your Recent History

LSE
0R2M
Regeneron Pharmaceuticals
BIT
I09527
XS2666911149 20260929 11...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads